Terms: = Skin cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Staging
10 results:
1. Swinging for the Fences: Long-Term Survival With Ipilimumab in Metastatic Melanoma.
Gibney GT; Atkins MB
J Clin Oncol; 2015 Jun; 33(17):1873-7. PubMed ID: 25964248
[TBL] [Abstract] [Full Text] [Related]
2. Asymptomatic brain metastases in patients with cutaneous metastatic malignant melanoma.
Zukauskaite R; Schmidt H; Asmussen JT; Hansen O; Bastholt L
Melanoma Res; 2013 Feb; 23(1):21-6. PubMed ID: 23117880
[TBL] [Abstract] [Full Text] [Related]
3. Advances and perspectives in immunotherapy of melanoma.
Schadendorf D; Vaubel J; Livingstone E; Zimmer L
Ann Oncol; 2012 Sep; 23 Suppl 10():x104-8. PubMed ID: 22987943
[TBL] [Abstract] [Full Text] [Related]
4. Malignant melanoma--future prospects.
Lugović L; Situm M; Kos L
Acta Dermatovenerol Croat; 2005; 13(1):36-43. PubMed ID: 15788145
[TBL] [Abstract] [Full Text] [Related]
5. Update on the systemic treatment of malignant melanoma.
Lawson DH
Semin Oncol; 2004 Apr; 31(2 Suppl 4):33-7. PubMed ID: 15124132
[TBL] [Abstract] [Full Text] [Related]
6. Therapy options in cutaneous T-cell lymphoma.
Apisarnthanarax N; Duvic M
Expert Rev Anticancer Ther; 2001 Oct; 1(3):403-20. PubMed ID: 12113107
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: second analysis of a randomised EORTC Melanoma Group trial comparing interferon-alpha2a (IFNalpha) and interleukin 2 (il-2) with or without cisplatin.
Keilholz U; Martus P; Punt CJ; Kruit W; Mooser G; Schadendorf D; Liénard D; Dummer R; Koller J; Voit C; Eggermont AM
Eur J Cancer; 2002 Jul; 38(11):1501-11. PubMed ID: 12110497
[TBL] [Abstract] [Full Text] [Related]
8. Phase-II randomized study of pre-operative il-2 administration in operable NSCLC.
Masotti A; Morandini G; Ortolani R; Fumagalli L
Lung Cancer; 1998 Jun; 20(3):191-202. PubMed ID: 9733054
[TBL] [Abstract] [Full Text] [Related]
9. Soluble interleukin-2 receptor serum levels in mycosis fungoides. Correlation with clinical stage.
Szeimies RM; Rueff F; Kaudewitz P
Cancer; 1992 Nov; 70(9):2338-41. PubMed ID: 1394062
[TBL] [Abstract] [Full Text] [Related]
10. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.
Clerici M; Stocks NI; Zajac RA; Boswell RN; Lucey DR; Via CS; Shearer GM
J Clin Invest; 1989 Dec; 84(6):1892-9. PubMed ID: 2574188
[TBL] [Abstract] [Full Text] [Related]
